Exploring multifunctional features of necrosis avid contrast agents

Academic Radiology

Volumn 9, Issue SUPPL. 2, 2002, Pages

  Ni, Yicheng ^a   Cresens, Erwin ^a   Adriaens, Paul ^a   Dymarkowski, Steven ^a   Bogaert, Jan ^a   Zhang, Hao ^a   Bosmans, Hilde ^a   Verbruggen, Alfons ^a   Marchal, Guy ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOPHRIN 2; MANGAFODIPIR; METALLOPORPHYRIN; MP 2269; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG; CEIV 7; CEIV-7; DRUG DERIVATIVE; ECIII 60; ECIII-60; EDETIC ACID; GADOPHRIN-2; MESOPORPHYRIN; N,N' BIS(PYRIDOXAL 5 PHOSPHATE)ETHYLENEDIAMINE N,N' DIACETIC ACID; N,N'-BIS(PYRIDOXAL-5-PHOSPHATE)ETHYLENEDIAMINE-N,N'-DIACETIC ACID; ORGANIC COMPOUND; PYRIDOXAL 5 PHOSPHATE;

ACUTE HEART INFARCTION; ANIMAL MODEL; BLOOD; CONFERENCE PAPER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG HALF LIFE; DRUG PROTEIN BINDING; HEPATOBILIARY SYSTEM; LIVER METASTASIS; LIVER NECROSIS; LIVER PERFUSION; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; RAT; SWINE; TISSUE SPECIFICITY; ANIMAL; ARTICLE; COMPARATIVE STUDY; HALF LIFE TIME; HEART INFARCTION; LIVER DISEASE; LIVER TUMOR; NECROSIS; PATHOLOGY; RHABDOMYOSARCOMA; TISSUE DISTRIBUTION;

ANIMALS; CONTRAST MEDIA; EDETIC ACID; GADOLINIUM DTPA; HALF-LIFE; LIVER DISEASES; LIVER NEOPLASMS; MESOPORPHYRINS; METALLOPORPHYRINS; MYOCARDIAL INFARCTION; NECROSIS; ORGANIC CHEMICALS; PYRIDOXAL PHOSPHATE; RATS; RHABDOMYOSARCOMA; SWINE; TISSUE DISTRIBUTION;

EID: 0036333617     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(03)80272-6     Document Type: Conference Paper

References (21)

1. Paramagnetic metalloporphyrins: From enhancers for malignant tumors to markers of myocardial infarcts
2. Validation of intracoronary delivery of metalloporphyrin as an in vivo "histochemical staining" for myocardial infarction with MR imaging
3. Necrosis avid contrast agents: Introducing nonporphyrin species
4. MRI Contrast enhancement of necrosis by MP-2269 and Gadophrin-2 in a rat model of liver infarction
5. Localization of metalloporphyrin induced "specific" enhancement in experimental liver tumors: Comparison of magnetic resonance imaging, microangiographic and histologic findings
6. Paramagnetic metalloporphyrins: Infarct avid contrast agents for diagnosis of acute myocardial infarction by magnetic resonance imaging
7. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis
8. Localization and determination of infarct size by Gd-mesoporphyrin enhanced MRI in dogs
9. Evaluation of interventional liver tumor ablation with Gd-mesoporphyrin enhanced magnetic resonance imaging
10. Myocardial viability
11. Contrast-enhanced MRI for quantification of myocardial viability
12. Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent
13. Will noninvasive techniques replace coronary angiography?
14. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats
15. Irreversibly damaged myocardium at MR imaging with a necrotic tissue-specific contrast agent in a cat model
16. MR contrast media for myocardial viability, microvascular integrity and perfusion
17. Do we need necrosis-avid contrast agents? (invited speech)
18. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media
19. New concepts in characterization of ischemically injured myocardium by MRI
20. Intracoronary delivery of Gd-DTPA and Gadophrin-2 for determination of myocardial viability with MR imaging
21. Cardiac MRI for assessment of myocardial perfusion: Current status and future perspectives